Left Atrial Remodelling in Hypertension: Effects of Ramipril or Irbesartan
Status:
Unknown status
Trial end date:
2010-08-01
Target enrollment:
Participant gender:
Summary
Aim of the study is to compare in hypertensive patients the effect of one year therapy with
ACE-inhibitor (RAMIPRIL) or angiotensin II receptor blocker (IRBESARTAN) on left atrial
remodelling and diastolic function.